Metagenomi Therapeutics, Inc. Share Price
NASDAQ: MGX | Micro CapMetagenomi Therapeutics, Inc. Stock Performance
Open $1.24 | Prev. Close $1.23 | Circuit Range N/A |
Day Range $1.24 - $1.24 | Year Range $1.13 - $3.93 | Volume 3,045 |
Average Traded $1.24 |
Metagenomi Therapeutics, Inc. Share Price Today
As of 10 August 2026, Metagenomi Therapeutics, Inc.'s share price is $1.23. The stock opened at $1.24, compared to its previous close of $1.23. During today's trading session, Metagenomi Therapeutics, Inc.'s share price traded between $1.24 and $1.24, with an average price of $1.24. Over the past 52 weeks, the stock has recorded a high of $3.93 and a low of $1.13. In terms of performance, Metagenomi Therapeutics, Inc.'s share price has declined by 19.61% over the last six months and is down 29.51% on a year-on-year basis.
Metagenomi Therapeutics, Inc. Share Price Chart
Metagenomi Therapeutics, Inc. Stock Fundamentals & Key Indicators
Market Cap $45.82M | PE Ratio (TTM) -0.52 | Dividend Yield N/A |
EPS (TTM) $-2.36 | Revenue (TTM) $25.21M | Return On Equity (TTM) -55.40% |
Profit Margin -348.54% | Debt to Equity 0.14 | Quarterly Earnings Growth YoY -8.63% |
Metagenomi Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
About Metagenomi Therapeutics, Inc.
Metagenomi, Inc., a genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. Its genome editing toolbox includes nuclease-based genome editing, base editors, RNA-mediated integration, including prime editing, and DNA-mediated integration, such CRISPR-associated transposases. The company has a collaboration and license agreement with Ionis Pharmaceuticals, Inc. to research, develop and commercialize investigational medicines using genome editing technologies; and a development, option, and license agreement with Affini-T Therapeutics, Inc. to develop and commercialize gene edited TCR-based therapeutic products exclusively in the field of treatment, prevention, or diagnosis of any human cancer. Metagenomi, Inc. was incorporated in 2016 and is headquartered in Emeryville, California.
Metagenomi Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $1.23 | $1.24 | +3.78% |
Jul 2026 | $1.18 | $1.19 | +0.42% |
Jun 2026 | $1.33 | $1.19 | -13.50% |
May 2026 | $1.34 | $1.37 | -0.72% |
Apr 2026 | $1.37 | $1.38 | +3.76% |
Mar 2026 | $1.49 | $1.33 | -13.07% |
Feb 2026 | $1.52 | $1.53 | -0.65% |
Jan 2026 | $1.64 | $1.54 | -5.23% |
Dec 2025 | $1.70 | $1.63 | -7.93% |
Nov 2025 | $2.54 | $1.76 | -30.37% |
Oct 2025 | $2.35 | $2.54 | +6.96% |
Sep 2025 | $1.77 | $2.37 | +35.82% |
MGX Share Price FAQs
What is Metagenomi Therapeutics, Inc. share price today?
What is the 52 week high and 52 week low of Metagenomi Therapeutics, Inc. stock?
What is MGX's market capitalisation today?
What is MGX's net income for the last quarter?
What is the 5 year returns of MGX?
What is the high & low stock price of MGX today?
Can I buy MGX shares in India?